KINSHASA, Democratic Republic of the Congo / RankWire.AI / – In response to the outbreak, health officials in the Democratic Republic of the Congo have launched a focused Ebola vaccination effort in Kisangani, the administrative center of Tshopo Province, aiming to halt the country’s most severe outbreak to date. Frontline healthcare workers, emergency response personnel, and individuals who have had direct contact with confirmed cases are being prioritized during the initial phase of the deployment. Health Minister Roger Kamba confirmed that the government initiated the immunization campaign utilizing doses of the Ervebo vaccine to safeguard frontline personnel operating across impacted eastern provinces.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
The health emergency has led international agencies, including the World Health Organization, to assist local teams with logistics, laboratory testing, and vaccine distribution. Authorities are administering the Ervebo vaccine under a compassionate-use framework while researchers observe its effectiveness against the circulating regional strain. DR Congo launches Ebola vaccination campaign as health workers intensify ring-vaccination strategies around identified infection clusters to isolate viral transmission chains.
DR Congo Commences Vaccination Efforts in Eastern Provinces Affected by Ebola
Operational challenges persist due to the region’s complex infrastructure, ongoing security issues, and high population movement across border districts. In Kisangani, cold-chain supply systems have been established to preserve the ultra-low temperatures necessary for vaccine storage before distribution to remote health zones. DR Congo begins Ebola vaccination efforts while civil defense and community health workers conduct outreach to enhance disease surveillance and reporting mechanisms.
Epidemiologists from the Africa Centres for Disease Control and Prevention are working closely with local teams to monitor adverse reactions and assess immune responses among vaccinated populations. Officials stressed that early clinical detection, combined with isolation procedures and supportive care, remains vital for improving patient survival chances. Additional vaccine supplies are scheduled for delivery as regional distribution broadens to secondary health districts.
Kisangani Acts as Central Hub for Regional Ebola Vaccine Distribution
National teams continue expanding contact-tracing efforts across urban and rural areas in the eastern region. Municipal health centers are equipped with personal protective equipment, diagnostic reagents, and therapeutic supplies to boost response capacity. The government has confirmed that public health measures will stay in place until data shows a sustained decline in transmission across all impacted provinces.
Officials have called on local populations to cooperate with mobile vaccination teams and follow sanitary guidelines strictly. It is anticipated that increasing immunization coverage among high-risk groups will help stabilize infection rates over the coming weeks. Surveillance networks will keep a close watch at transportation hubs and border points to prevent further spread geographically.